Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis

Date

2017

Authors

Costello, S.
Soo, W.
Bryant, R.
Jairath, V.
Hart, A.
Andrews, J.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Alimentary Pharmacology and Therapeutics, 2017; 46(3):213-224

Statement of Responsibility

S. P. Costello, W. Soo, R. V. Bryant, V. Jairath, A. L. Hart, J. M. Andrews

Conference Name

Abstract

Background: Faecal microbiota transplantation (FMT) is emerging as a novel therapy for ulcerative colitis (UC). Interpretation of efficacy of FMT for UC is complicated by differences among studies in blinding, FMT administration procedures, intensity of therapy and donor stool processing methods. Aim: To determine whether FMT is effective and safe for the induction of remis- sion in active UC. Methods: Medline (Ovid), Embase and the Cochrane Library were searched from inception through February 2017. Original studies reporting remission rates follow- ing FMT for active UC were included. All study designs were included in the sys- tematic review and a meta-analysis performed including only randomised controlled trials (RCTs). Results: There were 14 cohort studies and four RCTs that used markedly different protocols. In the meta-analysis of RCTs, clinical remission was achieved in 39 of 140 (28%) patients in the donor FMT groups compared with 13 of 137 (9%) patients in the placebo groups; odds ratio 3.67 (95% CI: 1.82-7.39, P< .01). Clinical response was achieved in 69 of 140 (49%) donor FMT patients compared to 38 of 137 (28%) placebo patients; odds ratio 2.48 (95% CI: 1.18-5.21, P=.02). In cohort studies, 39 of 168 (24%; 95% CI: 11%-40%) achieved clinical remission. Conclusions: Despite variation in processes, FMT appears to be effective for induc- tion of remission in UC, with no major short-term safety signals. Further studies are needed to better define dose frequency and preparation methods, and to explore its feasibility, efficacy and safety as a maintenance agent.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2017 John Wiley & Sons Ltd.

License

Call number

Persistent link to this record